Sunandamedi

GLENMARK - SHORT TERM

Long
Sunandamedi Updated   
NSE:GLENMARK   GLENMARK PHARM
2% MIN. OPPORTUNITY IS BEING SEEN. JOURNEY IS LONG AHEAD.
Comment:
To raise funds, Glenmark to divest stake in drug development arm Ichnos

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.